Liminal Biosciences Receives Final Court Order For Plan Of Arrangement With Structured Alpha LP
Portfolio Pulse from Benzinga Newsdesk
Liminal BioSciences Inc. (NASDAQ: LMNL) has received the final order from the Ontario Superior Court of Justice approving the plan of arrangement under which Structured Alpha LP will acquire all of the issued and outstanding common shares of Liminal BioSciences not currently owned by SALP or its affiliates and associates at a price of US$8.50 per Share.
September 19, 2023 | 8:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The court approval of the acquisition of Liminal BioSciences by Structured Alpha LP could potentially lead to a short-term increase in the stock price.
The acquisition news generally leads to an increase in the stock price of the company being acquired. In this case, Liminal BioSciences' shares are being acquired at $8.50 per share, which could potentially lead to a short-term increase in the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100